{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:39:45Z","timestamp":1790066385130,"version":"4.0.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.juro.2006.11.090","type":"journal-article","created":{"date-parts":[[2007,3,24]],"date-time":"2007-03-24T07:05:45Z","timestamp":1174719945000},"page":"1283-1286","source":"Crossref","is-referenced-by-count":130,"title":["Treatment Paradigm Shift May Improve Survival of Patients With High Risk Superficial Bladder Cancer"],"prefix":"10.1097","volume":"177","author":[{"given":"Ganesh V.","family":"Raj","sequence":"first","affiliation":[{"name":"Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Herr","sequence":"additional","affiliation":[{"name":"Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel M.","family":"Serio","sequence":"additional","affiliation":[{"name":"Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherri M.","family":"Donat","sequence":"additional","affiliation":[{"name":"Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard H.","family":"Bochner","sequence":"additional","affiliation":[{"name":"Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Vickers","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Dalbagni","sequence":"additional","affiliation":[{"name":"Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2006.11.090_bib1","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1464-410X.2003.04764.x","article-title":"Bacillus Calmette-Guerin therapy in stage Ta\/T1 bladder cancer: prognostic factors for time to recurrence and progression","volume":"93","author":"Andius","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2006.11.090_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000473593","article-title":"Local BCG failures in superficial bladder cancer","volume":"19","author":"Herr","year":"1991","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2006.11.090_bib3","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.1995.13.6.1404","article-title":"Intravesical bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial","volume":"13","author":"Herr","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2006.11.090_bib4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","article-title":"A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder","volume":"325","author":"Lamm","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2006.11.090_bib5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2006.11.090_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2003.09.013","article-title":"Bladder carcinoma in situ in 2003: state of the art","volume":"45","author":"Witjes","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2006.11.090_bib7","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0022-5347(05)67523-4","article-title":"Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin","volume":"163","author":"Brake","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2006.11.090_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0022-5347(17)38242-3","article-title":"Progression of stage T1 bladder tumors after intravesical bacillus Calmette-Guerin","volume":"145","author":"Herr","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2006.11.090_bib9","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1097\/01.ju.0000062605.92268.c6","article-title":"Defining bacillus Calmette-Guerin refractory superficial bladder tumors","volume":"169","author":"Herr","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2006.11.090_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00042307-200409000-00005","article-title":"Second-line intravesical therapy versus cystectomy for bacille Calmette-Guerin (BCG) failures","volume":"14","author":"Joudi","year":"2004","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.juro.2006.11.090_bib11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/01.ju.0000165340.53381.48","article-title":"The impact of provider volume on outcomes from urological cancer therapy","volume":"174","author":"Joudi","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2006.11.090_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1078-1439(03)00144-3","article-title":"Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy","volume":"22","author":"Bianco","year":"2004","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2006.11.090_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1078-1439(00)00061-2","article-title":"Timing of cystectomy for superficial bladder tumors","volume":"5","author":"Herr","year":"2000","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2006.11.090_bib14","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1200\/JCO.2006.05.8149","article-title":"Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?","volume":"24","author":"Weiss","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2006.11.090_bib15","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0090-4295(01)01187-6","article-title":"Risk of continued intravesical therapy and delayed cystectomy in BCG-refractory superficial bladder cancer: an investigational approach","volume":"58","author":"Luciani","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.juro.2006.11.090_bib16","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0022-5347(05)65756-4","article-title":"Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?","volume":"166","author":"Herr","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2006.11.090_bib17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.urology.2005.10.012","article-title":"Radical cystectomy after bacillus Calmette-Guerin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservation","volume":"67","author":"Nieder","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.juro.2006.11.090_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ucl.2005.01.001","article-title":"Radical cystectomy for bladder cancer: the case for early intervention","volume":"32","author":"Chang","year":"2005","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.juro.2006.11.090_bib19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534706030898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534706030898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2006.11.090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:10:11Z","timestamp":1784902211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.juro.2006.11.090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1016\/j.juro.2006.11.090"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2006.11.090","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1148128.605254","asserted-by":"object"}]},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}